76 results about "Tuberculosis liver" patented technology

The invention provides a medicament for treating pulmonary tuberculosis. Adenophora root, Tuber of Dwarf Lilyturf, asparagi radix, rehmanniae radix, Rehmannia Glutinosa, stemona, tendril-leaved fritillary bulb, donkey-hide gelatin, pseudo-ginseng, Poria cocos, Chinese yam, polyghace seche, lily, bletilla striata, hairyvein agrimony, cortex lycii, isoniazid and vitamin B6 are mixed uniformly, and crushed into a medicinal powder of 80-120 mesh; and the medicinal powder is disinfected and filled into capsules to obtain the capsule product. The medicament is composed of traditional Chinese medicines and Western medicines, has efficacies of resisting tuberculosis, disinfesting, supporting right, securing the root, nourishing yin, reliving cough, reducing phlegm and stopping bleeding, and can play fast curative effect without side effect on treatment of pulmonary tuberculosis.

The invention discloses a Chinese traditional medicine composition for treating phthisis, belonging to a Chinese traditional medicine preparation. The Chinese traditional medicine composition is prepared from the following raw material medicines by weight: 20g of milk vetch, 20g of tuckahoe, 20g of radix rehmanniae, 15g of angelica, 15g of lily, 15g of white peony root, 15g of houttuynia, 15g of oyster, 15g of Chinese yam, 12g of root-bark of Chinese wolfberry, 12g of earthworm, 10g of aweto, 10g of shiandra, 10g of placenta hominis, 10g of polygala tenuifolia, 10g of rhizoma bletillae, 10g of pinellia ternata, 10g of dangshen, 10g of coix seed, 10g of balloon flower and 6g of licorice. The Chinese traditional medicine composition of the invention has the functions of invigorating qi and nourishing the kidney, clearing heat and eliminating toxins, moistening the lung and relieving the cough, and nourishing yin and strengthening yang. The medicine of the invention has high cure rate and small side effect. By taking the Chinese traditional medicine composition for treating 100 patients suffering from the phthisis through one course of treatment in three months, the results show that 94 cases are cured, 4 cases are effective, and the total effective rate reaches 98%.

The invention discloses a traditional Chinese medicinal composition for treating phthisis. The traditional Chinese medicinal composition comprises the following raw materials in parts by weight: 10-15 parts of asparagus cochinchinensis, 5-10 parts of radix polygonati officinalis, 15-20 parts of lily, 10-15 parts of radix glehniae, 18-24 parts of mulberry, 16-22 parts of platycodon grandiflorum, 15-20 parts of radix scrophulariae, 10-15 parts of donkey-hide gelatin, 5-10 parts of tortoise shell, 12-18 parts of raw rehmannia, 10-15 parts of pitaya flower, 5-10 parts of rhizoma atractylodis macrocephalae, 10-15 parts of astragalus membranaceus, 12-18 parts of aster, 8-14 parts of humulone, 5-10 parts of yam, 10-15 parts of codonopsis pilosula, 5-10 parts of polygonatum, 10-15 parts of apricot kernel, 15-20 parts of Japanese ardisia stem, 10-15 parts of medlar, 16-22 parts of radix stemonae, 12-18 parts of bearded dead nettle root, 10-15 parts of bletilla striata, 5-10 parts of turtle shell, 6-12 parts of bulbus fritillariae cirrhosae, 8-14 parts of radix ophiopogonis and 10-15 parts of pink reineckea herb. The compatibility of the medicines has the effects of tonifying kidneys and qi, strengthening spleen, tonifying lung, activating blood circulation, stopping bleeding, relieving cough, reducing sputum, clearing heat and purging fire, and the like, is remarkable in curative effect when used for treating phthisis, has the advantages of stable drug effect, quick acting and response, short course of treatment, high cure rate and no toxic or side effect, does not damage patient body, can reinforce physical constitution of patients, and can treat both symptoms and root causes.

The invention discloses a traditional Chinese medicine combination for treating tuberculosis and belongs to the field of traditional Chinese medicines. According to the traditional Chinese medicine combination, fragrant solomonseal rhizome, lily, common bletilla pseudobulb, lalang grass rhizome, agrimonia pilosa ledeb, houttuynia cordata, white mulberry root-bark, panax notoginseng powder, stemona, turtle shell, licorice and tree peony bark are adopted to be combined, interact and complement and benefit each other. The traditional Chinese medicine combination has the effects of nourishing yin and moistening the lung, relieving a cough and eliminating phlegm. The traditional Chinese medicine combination is low in medicine cost and free of any side effect, the therapeutic effect is remarkable, the total effective rate in one course of treatment is 95%, and the total effective rate in two courses of treatment is 97.5%.

The invention relates to a sample containing a tuberculosis serum characterized protein and a preparation method thereof. The sample comprises the serum of an untreated patient suffering from active tuberculosis, and the serum protein of a patient suffering from lung cancer, a patient suffering from pneumonia, a patient suffering from chronic obstructive pulmonary disease or a healthy person who is ensured to be normal by physical examination, wherein the serum protein comprises three up-regulated proteins and one down-regulated protein; the proteins exit independently or any or all of the proteins are mixed together; and the sample is suitable to be detected by using mass spectrum. The sample provides a basis for further discovering new active tuberculosis biomarkers. By using the sample, the detection of the active tuberculosis is superior to any single detection method adopted currently; a non-invasive technology for early discovery and early treatment of the active tuberculosis is provided; and therefore, a new method for reducing the infectious rate of the active tuberculosis and improving the recovery rate of the tuberculosis is provided.

The invention discloses an internal medicine for treating phthisis. The internal medicine is a Chinese herbal medicine compound preparation prepared from dendrobium officinale, panax japonicas, senior tile, circium japonicum, fritillaria cirrhosa, radix fici simplicissimae, radix asparagi, Chinese pholidota herb, rhizoma bletillae, pink reineckea herb, radix ophiopogonis, polygonum filiforme, Yunnan bulbophyllum herb, spiranthes sinensis ames, rhizoma polygonati, rattlesnake plantain, ardisia japonica and platycodon grandiflorum. The drug disclosed by the invention is significant in curative effect, available in raw materials, convenient to take, relatively short in treatment period, low in cost and good in integrative effect, and can be used for treating both symptoms and root causes, and the phthisis does not easily reappear once being cured. By adopting the medicine for treating phthisis, the effective rate can be up to 95%, the recovery rate can be up to 85%, and the recovery rate on multidrug resistance tuberculosis can be up to about 50%; meanwhile, the internal medicine also has good prevention and auxiliary treatment effects on the lung cancer.

The invention relates to a special Chinese patent medicine for resisting phthisis-astragalus fritillaria capsules, which is prepared from 120-150g of radix astragali, 20-50g of aweto, 80-100g of gecko, 50-80g of fritillaria cirrhosa, 50-70g of stemona, 48-70g of lily root, 30-50g of ginkgo, 56-76g of hyacinth bletilla, 120-150g of coix seed, 20-50g of radix glehniae, 80-102g of radix rehmanniae preparata, 60-85g of radix ophiopogonis, 55-75g of tuckahoe, 80-130g of taraxacum and 60-75g of oyster. The Chinese patent medicine not only can be made into capsules according to the formula of the composition, but also can be made into tablets, pills, powder and oral liquids according to the formula of the composition. The capsules are prepared from Chinese medicinal herbs, and can treat tuberculosis (mainly phthisis) by utilizing the comprehensive conditioning actions of the Chinese medicinal herbs; the capsules can not generate toxic or side effect, and also can not generate drug resistance, and the effective rate is up to more than 95%; and the capsules can be combined with other antituberculosis medicines to enhance the curative effect (especially for drug-resistant strain infected cases), and can also be independently used for patients who are allergic to western antituberculosis medicines or can not stand for the toxic or side effect.

The invention relates to a traditional Chinese medicine composition for treating pulmonary tuberculosis. The traditional Chinese medicine composition is characterized in that: the effective medicinal composition is prepared from the following raw material components: radix stemonae, bletilla striata, radix ranunculi ternate, radix adenophorae, radix ophiopogonis, dried radix rehmanniae, radix scrophulariae, radix polygoni multiflori preparata, schisandra chinensis, polygonatum sibiricum, processed carapax trionycis, bulbus fritillariae cirrhosae, angelica sinensis, rhizoma chuanxiong, parched white peony roots, radix rehmanniae preparata, radix panacis quinquefolii, roasted rhizoma atractylodis macrocephalae, poria, radix glycyrrhizae preparata, radix astragali, rhizoma imperatae, rubia cordifolia, dried tangerine or orange peels and Jiao sanxian, namely, scorched malt, scorched hawthorn fruit and scorched medicated leaven. The traditional Chinese medicine composition has the following advantages: through the use of the medicine for treating pulmonary tuberculosis provided by the invention, pulmonary tuberculosis can be quickly cured around one month, and is not easy to relapse under the condition that a patient obeys the doctor's advice; as a pure traditional Chinese medicine preparation, the composition is few in toxic and side effects and free of dependency; the medicine for treating pulmonary tuberculosis has dual functions, not only can improve the disease resistance of human bodies, but also can kill tubercule bacillus, so that the treating speed is high, and pulmonary tuberculosis does not relapse; the composition is few in toxic and side effects and free of dependency.

Belonging to the technical field of traditional Chinese medicines, the invention discloses a traditional Chinese medicine for treating tuberculosis. The traditional Chinese medicine is prepared from the following bulk drugs by weight: 20g of codonopsis pilosula, 18g of medlar, 15g of Ligustrum lucidum, 20g of Chinese yam, 10g of Gorgon fruits, 10g of bighead atractylodes rhizome, 18g of turtle shell, 12g of polygonatum odoratum, 20g of dendrobe, 12g of Radix Sophorae subprostratae, 18g of Curcuma aromatic, 10g of Radix Peucedani, 25g of gypsum, 10g of Cortex Lycii, 8g of Anemarrhena, 12g of forsythia, 12g of Houttuynia cordata, 15g of Fructus Trichosanthis, 10g of Concretio Silicea Bambusae, 8g of Red Paeony Roots, and 5g of Chinese dates. The traditional Chinese medicine can nourish liver and kidney, nourish Yin to decrease internal heat, nourish lung and consolidate jin, effectively inhibits the breeding of Mycobacterium tuberculosis, and enhances the human body resistance, thereby effectively treating tuberculosis.

The invention discloses a protein TRIM27 resistant to mycobacterium tuberculosis infection and belongs to the field of cell biology. The protein TRIM27 resistant to mycobacterium tuberculosis infection can be used for developing a drug for treating phthisis or a JNK/p38 signal pathway activating agent or an NF-KappaB signal pathway inhibitor, a new thought and a molecular target are provided for research of novel anti-tuberculosis drugs, and especially the protein TRIM27 has a wide prospect on the development aspects of a variety of drugs resistant to tuberculosis and the like.

The invention relates to a compound Chinese medicine for treating multidrug-resistant tuberculosis, which is prepared from following raw medicinal materials: 15 to 20 grams of manyflower solomonseal rhizome, 10 to 20 grams of common bletilla tuber, 15 to 20 grams of heterophylly falsestarwort root, 10 to 15 grams of sessile stemona root, 15 to 20 grams of Japanese ardisia herb, 10 to 15 grams of common coltsfoot flower, 15 to 20 grams of Phippine violet herb, 10 to 12 grams of Japanese thistle herb or root, 15 to 20 grams of cochinchinese asparagus root, and 15 to 20 grams of turtle shell. The compound Chinese medicine capable of treating multidrug-resistant tuberculosis can enhance a curative effect, and has functions of nourishing Yi, moistening lung, killing parasites, eliminating phlegm, removing blood stasis and promoting tissue regeneration. The compound Chinese medicine provided by the invention integrates a western chemotherapy regimen to treat multidrug-resistant tuberculosis, and also can accelerate sputum conversion, promote the absorption of focus, improve immunity, and accelerate the recovery of tuberculosistoxic symptoms.

The invention discloses a traditional Chinese medicine preparation for treating phthisis and a preparation method thereof, and belongs to the field of traditional Chinese medicine. The traditional Chinese medicine preparation includes the following active ingredients as raw materials: cucubalus root, scandent hop, chestnut leaf, asclepias physocarpa, ardisia japonica, wormseed mustard, sunglo, lemmaphyllum microphyllum, tatarian aster root, pyrostegia venusta, fern, hibiscus trionum, pig bone, meconopsis punicea, pawpaw and ginkgo. The traditional Chinese medicine preparation is proper in compatibility of the selected medicinal materials, and accords with the theories of the traditional Chinese medicine and pharmacy and the modern medicine and pharmacology; the traditional Chinese medicine preparation has the effects of moistening lung to arrest cough, clearing heat and diminishing inflammation, cooling blood and hemostasis, and relieving swelling and pain, and is remarkable in curative effect on treating the phthisis caused by symptoms such as cough, expectoration, hemoptysis, chest pain, chest distresses of different degrees and dyspnea, safe and reliable without any toxic and side effects, short in course of treatment, quick in taking effect and low in cost, and also capable of achieving the purpose of treating both symptoms and root causes and thus worthy of clinically wide popularization and application.

The invention provides application of Rv1860, Rv0173 and/or Rv1812c protein in development and/or designing of products capable of discrimination, diagnosis, auxiliary diagnosis, screening and/or auxiliary screening of active tuberculosis. The invention further provides protein chips prepared by using Rv1860, Rv0173 and Rv1812c. The protein chips prepared in the invention are used for detecting the levels of IgG antibodies respectively corresponding to three protein antigens in serum of a patient with active tuberculosis and of a normal person, and detection results of the antibodies respectively corresponding to the three protein are analyzed together so as to determine whether an examined person suffers from active tuberculosis; detection results show that optimal operating points of the protein chips provided by the invention in auxiliary diagnosis of active tuberculosis have specificity of 83.0% and sensitivity of 73.1%, both higher than indexes of diagnosis of active tuberculosis in the prior art.

The invention discloses application of miR-31-5p and miR-99a-5p in distinguishing active tuberculosis and latent tuberculosis infection. Substances for detecting the expression quantity of miR-31-5p comprise a reagent and an instrument which are used for detecting the expression quantity of the miR-31-5p by using quantitative PCR (polymerase chain reaction) and a reagent and an instrument which are used for detecting the expression quantity of the miR-31-5p by using an RNA-Seq; and substances for detecting the expression quantity of miR-99a-5p comprise a reagent and an instrument which are used for detecting the expression quantity of the miR-99a-5p by using the quantitative PCR and a reagent and an instrument which are used for detecting the expression quantity of the miR-99a-5 by using the RNA-Seq. The AUC of the miR-31-5p and the miR-99a-5p which are used for distinguishing an active tuberculosis patient and a latent tuberculosis infection patient is greater than 0.8, and the specificity is high; and the miR-31-5p and the miR-99a-5p can be used for distinguishing the active tuberculosis and the latent tuberculosis infection.

The invention discloses a medicine pill for treating tuberculosis and a preparation method thereof, and belongs to the field of food manufacturing. The medicine pill for treating tuberculosis is prepared from the following raw materials in parts by weight: 160 to 200g of radix stemonae, 40 to 50g of rizoma betillae, 50 to 60g of dried tangerine peel, 50 to 60g of bulbus fritillariae cirrhosae, 130to 140g of blbus fitillariae tunbergii, 85 to 95g of lumbricus, 85 to 95g of gecko, 40 to 50g of talcum, 40 to 50g of radix ginseng rubra, 450 to 550g of chicken meat and 130 to 140g of radix astragali seu hedysari. The preparation method comprises the following steps of grinding various medicinal materials, and sterilizing for further use; selecting the bone-removed chicken meat, blanching, andboiling into the concentrated juice of chicken meat; mixing the concentrated juice of chicken meat and the powder of medicinal materials, and drying and pilling by a traditional Chinese medicine pilling machine at high temperature. The medicine pill has the advantages that the infiltrative tuberculosis, pulmonary infection and cavernous tuberculosis can be regulated and treated; for the deficiencyof kidney Qi of the patient, the medicines with effects of killing tuberculosis worms, strengthening the body resistance, removing phlegm, stopping blood circulation, stopping cough, supplementing blood, tonifying the spleen and tonifying the kidney are taken, the treatment effect is obvious, and the tuberculosis can be completely healed; the chicken meat is boiled and is prepared into pills to take, and the chicken meat is used for moistening, tonifying the lung, and nourishing Qi and blood, so that any toxic or side effect on the patient is avoided.

The invention discloses a sniffing medicine for treating tuberculosis and a preparation method thereof. The sniffing medicine for treating tuberculosis disclosed by the invention comprises the following bulk pharmaceutical components in parts by weight: 1-2 parts of lead sulfate, 20-40 parts of calomel, 20-40 parts of vermilion, 40-80 parts of croton seeds and 300-600 parts of red jujubes. The preparation method of the sniffing medicine for treating tuberculosis disclosed by the invention comprises the following steps: removing pits of the red jujubes, and then sequentially placing the croton seeds, the lead sulfate, the calomel and vermilion in parts by weight in the red jujubes; then, wrapping the red jujubes three layers by using cabbage leaves, and roasting the obtained product 15-30 minutes by using charcoal fire; and finally, removing the cabbage leaves, and grinding the red jujubes into paste. The effect of the sniffing medicine on treating diseases such as tuberculosis and the like is obvious. The sniffing medicine is taken orally, and does not hurt the stomach, intestines, the liver and the kidney; and the sniffing medicine treats liver complaints, and the sniffing medicine directly reaches the lungs and enters the blood circulation so as to achieve effects of toxic substance counteracting, sterilization and parasite control.

The invention discloses a traditional Chinese medicinal composition for treating primary tuberculosis. The traditional Chinese medicinal composition consists of the following traditional Chinese medicinal components in parts by weight: 10 to 25 parts of platycodon grandiflorum, 10 to 20 parts of houttuynia cordata, 10 to 30 parts of radix stemonae, 10 to 30 parts of asparagus cochinchinensis, 5 to 15 parts of cooked jujube kernel, 10 to 20 parts of bulbus fritillariae cirrhosae, 10 to 30 parts of radix ophiopogonis, 10 to 20 parts of cortex lycii radicis, 10 to 30 parts of rhizoma anemarrhenae, 10 to 30 parts of bletilla, 10 to 25 parts of rhizoma nelumbinis, and 5 to 15 parts of prepared licorice. According to the traditional Chinese medicinal composition, the symptoms, such as cough, polypnea with profuse sputum, fetid sputum and hoarseness, of patients can be improved obviously; the effects, such as tonifying the lung and promoting fresh blood production, invigorating the spleen and supplementing qi, moisturizing dryness by nourishing yin, and preventing phlegm from forming and stopping coughing are achieved. The traditional Chinese medicinal composition is rigorous in formula, has few medicines and concentrated efficacy, and has a good effect on tuberculosis.

The invention provides a medicine for treating tuberculosis. The medicine is prepared from lilies, radix scrophulariae, tendril-leaved fritillary bulb, radix platycodi, radix ophiopogonis, radix paeoniae alba, radix angelica sinensis, radix stemonae, radices stellariae dichotomae, rhizoma picrorhizae, hairyvein agrimonia herb and buds, dried rehmannia roots, fried turtle shells, milkvetch roots, radix scutellariae, radix sophorae subprostratae, cordate houttuynia, fructus forsythia, dandelions, herba violae, polygala roots, almond apricots, rhizoma anemarrhenae, liquorice roots and the like. The raw materials are common Chinese herbal medicine, and are wide in source and low in price, the medicine formulation is scientific and reasonable, the components collaborate, tubercle bacillus can be rapidly killed, and the medicine is used for treating tuberculosis, and has the advantages of being rapid in effect taking and good in treatment effect.

The invention discloses a traditional Chinese medicine for treating tuberculosis and a preparation method thereof. The traditional Chinese medicine comprises the following components in parts by weight: 3g of herba asari forbesii, 4g of cudweed herb, 10g of lucid ganoderma, 7g of hemp fimble leaf, 8g of semen oroxyli, 20g of radix raphani sativi, 6g of burdock root, 10g of rhizoma rehmanniae, 10g of rhizoma picrorhizae, 12g of rhizoma cyperi, 12g of radix ophiopogonis, 9g of galla chinensis and 9g of radix glycyrrhizae. The preparation method of the traditional Chinese medicine for treating tuberculosis comprises the following steps: weighing medicinal materials according to the formula, uniformly mixing the weighed medicinal materials, then washing the medicinal materials, cutting the medicinal materials, then drying the medicinal materials till the water content is smaller than 1%, then grinding, sieving via a 80-mesh sieve, putting the prepared mixture into a muslin bag, decocting for 40 minutes over strong fire, then decocting for 20 minutes over soft fire, and filtering via gauze to obtain filtrate. The traditional Chinese medicine for treating tuberculosis has the functions of dispelling wind and eliminating cold, dissolving phlegm and inducing dieresis, activating blood and relieving asthma, relieving pain and replenishing heart blood, tonifying heart qi, calming mind, replenishing lung qi and warming lung and reducing phlegm; the traditional Chinese medicine is neutral and slightly mild in nature.

The invention provides a powdery Chinese patent medicine externally applied to feet of patients for treating tuberculosis and lung tumor, and belongs to Chinese patent medicines. Wild ganoderma lucidum, unibract fritillary bulbs, bletilla striata, raw lily, platycodon grandiflorum, almond, borneol, musk and the like are mixed together and crushed to prepare the powdery Chinese patent medicine. The powdery Chinese patent medicine is externally applied to the feet of the patients for treatment, and is easy and convenient to use, and the tuberculosis and the lung tumor of the patients can be cured without additional orally taken Chinese or western medicines or injection of other Chinese or western medicines. The duration for a curing process by the powdery Chinese patent medicine is short, a general patient only needs to use the medicine for 3 to 9 days, a critical patient needs 10 to 18 days to treat diseases (obsolete tuberculosis) by the powdery Chinese patent medicine (without other medicines), and the diseases rarely relapse after the patients are treated by the powdery Chinese patent medicine (having curative effect for various types of tuberculosis).

The invention discloses a Chinese medicinal preparation for treating tuberculosis. The Chinese medicinal preparation is prepared from Chinese thorowax root, unibract fritillary bulb, scutellaria laterifolia, poria, halfsummer, dried orange peel, apricot kernel, Chinese magnoliavine fruit, platycodon root, white mulberry boot-bark, dwarf lilyturf root, liquoric root and common lophatherum herb in a certain proportion. The Chinese medicinal preparation comprises tablets, particles and capsules, and is high cure rate and effective rate; and through clinical verification, the Chinese medicinal preparation does not have any side effect.

The invention discloses a traditional Chinese medicine composition for treating lung and kidney yin deficiency and a preparation method thereof and belongs to the technical field of traditional Chinese medicine compositions. The traditional Chinese medicine composition comprises radix stemonae, Bletilla striata, radix glycyrrhizae, cordyceps sinensis and spinach seeds. The preparation method includes: crushing the cordyceps sinensis; repeatedly decocting the radix stemonae, the Bletilla striata, the radix glycyrrhizae and the spinach seeds, and collecting filtrate; combining the filtrate, andperforming vacuum concentration; using ethanol to remove the impurities of concentrate; adding the cordyceps sinensis powder, and performing reduced-pressure drying; adding auxiliary materials to prepare a dosage form. The traditional Chinese medicine composition has effects of nourishing the lung and tonifying the kidney, relieving cough and reducing phlegm and promoting granulation and hemostasis, has an evident curative effect on respiratory system diseases caused by lung and kidney yin deficiency, and can delay the generation of the drug resistance of mycobacterium tuberculosis and reducecomplications such as drug-induced liver injury when being used to assist phthisis treatment. The traditional Chinese medicine composition is simple in formula, reasonable and feasible in preparationprocess, controllable in quality, definite in curative effect and suitable for large-scale production.

The invention belongs to the technical field of medicines, and specifically relates to a traditional Chinese medicine composition for treating phthisis. The traditional Chinese medicine composition is composed of the following medicines: adenophora tetraphylla, radix ophiopogonis, radix stemonae, radix rehmanniae, pseudo-ginseng, rhizoma anemarrhenae, pericarpium citri reticulatae, light wheat, astragalus membranaceus and coix seeds. The traditional Chinese medicine composition disclosed by the invention is reasonable in prescription and easy to prepare, has the remarkable curative effects of nourishing yin and moisturizing lung, invigorating qi and strengthening superficies, tonifying spleen and clearing dampness, and promoting salivation and reducing phlegm, as well as is an effective medicine for treating phthisis.

The invention relates to a traditional Chinese medicine composition for pulmonary tuberculosis, which is composed of raw materials in the following weight proportions: 10-40g of red ginseng, 1-3 pairs of geckos, 15-35g of notoginseng, 200-300g of a hundred parts, Bletilla striata 50-150g, Asparagus 50-70g, Ophiopogon japonicus 50-70g, Imperata 100-200g, Scutellaria baicalensis 8-28g, Salvia miltiorrhiza 2-22g. The traditional Chinese medicine composition of the present invention adopts natural Chinese herbal medicine, and has the functions of killing insects and sterilizing, clearing heat and detoxifying, nourishing yin and nourishing qi, nourishing yin and moistening dryness, nourishing blood and promoting body fluid, dispelling blood stasis and stopping bleeding, clearing heart and nourishing lung and kidney, relieving cough and relieving qi and relieving asthma The total effective rate is 80%, and the cure rate is 62.2%.

The invention discloses a traditional Chinese medicinal preparation for treating tuberculosis, and belongs to the technical field of traditional Chinese medicine. Aiming at the pathogenesis of the tuberculosis, the inventor decocts traditional Chinese medicine with the effect of clearing heat and toxic materials, tonifying yin, moistening the lung, relieving cough and reducing sputum in water to obtain a decoction according to the traditional Chinese medicinal theory of diagnosing and treating based on overall analysis of illnesses and patient's conditions, wherein the traditional Chinese medicine includes radix ranunculi ternati, leleba oldhami slices, aleuritopteris, sweet clover roots, setaria geniculate, canscora lucidissima, woolly grape ferns, sagittaria guyanensis, Chinese avens, the rhizome of large-leaf Japanese ginseng, common nepenthes, phyllanthus emblica, humulus scandens and castanea seguinii. Clinical experiments show that total effective rate reaches 95%.